Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.
about
Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremiaFuture challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSAMannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureusEffectiveness of a bundled intervention of decolonization and prophylaxis to decrease Gram positive surgical site infections after cardiac or orthopedic surgery: systematic review and meta-analysisReduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsDalbavancin in the treatment of complicated skin and soft-tissue infections: a reviewImproving Clinical Outcomes in Patients With Methicillin-Sensitive Staphylococcus aureus Bacteremia and Reported Penicillin AllergyMechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolonesPotential role for telavancin in bacteremic infections due to gram-positive pathogens: focus on Staphylococcus aureusCationic antimicrobial peptide LL-37 is effective against both extra- and intracellular Staphylococcus aureusSynergy between vancomycin and nafcillin against Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic modelEmpiric antibiotic therapy for Staphylococcus aureus bacteremia may not reduce in-hospital mortality: a retrospective cohort studyAcute bacterial skin and skin structure infections in internal medicine wards: old and new drugs.Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus?Treatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study.Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial.Thrombocytopaenia during methicillin-sensitive Staphylococcus aureus bacteraemia.Epidemiology of community-onset Staphylococcus aureus infections in pediatric patients: an experience at a Children's Hospital in central Illinois.Rapid identification of bacteria from positive blood culture bottles by use of matrix-assisted laser desorption-ionization time of flight mass spectrometry fingerprintingCharacteristics of invasive Staphylococcus aureus infections in three regions of Korea, 2009-2011: a multi-center cohort studyCephalosporin-Glycopeptide Combinations for Use against Clinical Methicillin-Resistant Staphylococcus aureus Isolates: Enhanced In vitro Antibacterial Activity.Real-time PCR testing for mecA reduces vancomycin usage and length of hospitalization for patients infected with methicillin-sensitive staphylococci.A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study.Clinical and Microbiological Determinants of Outcome in Staphylococcus aureus BacteraemiaTolerability of cefazolin after immune-mediated hypersensitivity reactions to nafcillin in the outpatient setting.Intra- and extracellular activities of dicloxacillin against Staphylococcus aureus in vivo and in vitro.Establishment of a superficial skin infection model in mice by using Staphylococcus aureus and Streptococcus pyogenesOutcomes with daptomycin in the treatment of Staphylococcus aureus infections with a range of vancomycin MICs.Determinants of methicillin-susceptible Staphylococcus aureus native bone and joint infection treatment failure: a retrospective cohort studyClinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.Clinical management of Staphylococcus aureus bacteremia: a review.The role of vancomycin in the persistence or recurrence of Staphylococcus aureus bacteraemia.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Staphylococcus aureus infection induces protein A-mediated immune evasion in humans.Intra- and extracellular activities of dicloxacillin and linezolid against a clinical Staphylococcus aureus strain with a small-colony-variant phenotype in an in vitro model of THP-1 macrophages and an in vivo mouse peritonitis model.Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremiaGenetic and molecular predictors of high vancomycin MIC in Staphylococcus aureus bacteremia isolates.Reversible antibiotic tolerance induced in Staphylococcus aureus by concurrent drug exposure.High cell-free DNA predicts fatal outcome among Staphylococcus aureus bacteraemia patients with intensive care unit treatment.Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial.
P2860
Q21261829-11CC6271-8FCB-482C-AC35-EAE19CA55D7FQ22305769-6A2E566A-1D72-46E0-88C1-2CD74029DF14Q24293487-9CFB867D-7E76-44CB-B96D-1B6E74D65F4FQ24613157-D813DE6A-7096-4F42-A266-B70FC025B237Q24646677-E4395D99-1C1E-4285-A6CC-254484CF8F91Q24647429-B234AD6F-34DA-459A-AB63-4325A9116DF6Q26779453-63A6D473-F298-4E6B-B992-2A6042FADE0FQ26828604-2D128E23-552B-475C-9A51-651C11719AFBQ27027412-A4361880-EFF0-4DAC-8AA5-430965BDF71EQ28395363-ED5E4624-8EC8-4334-B142-69FD20CA09F4Q28481497-11D72CF5-B41E-4157-9635-3453FB2E820DQ28750538-34545DDB-2DDC-47A4-8A40-D4DC790AF8AEQ30251580-C7065194-764E-415B-9C0E-5447B1A0FFCDQ30424717-6A5800A5-0E5F-44D8-8145-882BBEEEEA90Q30449846-6EC277BC-FE0D-4F48-AE0E-5B9B915D652CQ30667465-A814AFEF-1765-4986-B56C-81E46F10C4CAQ33437851-90D5D261-A0A7-4984-B433-6B3758BFB365Q33483064-40300F80-B7DE-4BC5-AC5A-E57DBD96B3B8Q33541809-2AC4B1CC-6FCA-4F17-9946-54392872766DQ33644439-455400F4-19F6-41B3-82D8-06821E5B42E1Q33700986-C30B3D0E-73E8-4ECA-98DE-3789B656BFF1Q33704733-34927BC7-BF22-42A3-8209-E1E64A7574BCQ33723124-E0A187D3-4CFC-4A17-8F19-AFE27CE945F7Q33734119-7F410111-1524-46BB-B30C-1FAFE74E3103Q33797925-F7842AAB-1424-4408-85F5-E43FF7C54DD5Q33876454-3E281283-BCD4-4C07-A90A-BDB521F1E19EQ33938185-51ACAC98-F76B-4640-A3CE-895509A171A1Q33997671-D5641C7E-FD7C-4A4B-B5A5-954FD1AB36B2Q34100226-668E34A1-8EA3-42AE-99D7-019B4573D359Q34157657-92ED2FCF-36C4-4F4B-8F37-6A07F3801EC1Q34441035-F58A5696-44D2-4268-BE21-582CB6BC0732Q34447860-B090B198-C3D5-4764-8E45-464DC3DCF86BQ34478074-585DBC1A-9305-4FC4-904E-89B1F83DF9F4Q34533083-A4EEDDA9-7E93-498C-9F86-5FEC85855067Q34737534-B1B5ADEA-5534-4B05-8D8A-29EC29137C65Q34973729-C3737788-9A9B-40AF-B23D-E5F41BDD73E2Q35035799-B30EBDF1-D5E9-4AE7-A7AB-D818431A9324Q35038242-299B4A15-7C40-4B0A-B5C5-EFEF25966189Q35092654-45C7CBA9-9E8E-492A-A136-786117FEB2D1Q35179800-54DF35BE-72DC-498E-97FF-5F17F8F7BE27
P2860
Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Staphylococcus aureus bacterem ...... prospective multicenter study.
@ast
Staphylococcus aureus bacterem ...... prospective multicenter study.
@en
Staphylococcus aureus bacterem ...... prospective multicenter study.
@nl
type
label
Staphylococcus aureus bacterem ...... prospective multicenter study.
@ast
Staphylococcus aureus bacterem ...... prospective multicenter study.
@en
Staphylococcus aureus bacterem ...... prospective multicenter study.
@nl
prefLabel
Staphylococcus aureus bacterem ...... prospective multicenter study.
@ast
Staphylococcus aureus bacterem ...... prospective multicenter study.
@en
Staphylococcus aureus bacterem ...... prospective multicenter study.
@nl
P2093
P1433
P1476
Staphylococcus aureus bacterem ...... prospective multicenter study.
@en
P2093
Alice O'Donnell
Brent B MacDonald
Daniel M Musher
Feng-Yee Chang
James E Peacock
Joseph M Mylotte
Marilyn M Wagener
Patricia Triplett
Victor L Yu
P304
P356
10.1097/01.MD.0000091184.93122.09
P407
P577
2003-09-01T00:00:00Z